AUC | 95% CI | P value | |
---|---|---|---|
Model 1. Before cataract surgery Eyes with pre-onset of malignant glaucoma vs. Matched eyes | |||
ACD | 0.51 | 0.35–0.66 | 0.923 |
ACW | 0.61 | 0.47–0.76 | 0.128 |
LV | 0.58 | 0.43–0.74 | 0.268 |
STS | 0.61 | 0.47–0.76 | 0.133 |
AVD | 0.52 | 0.37–0.67 | 0.756 |
CBTmax | 0.74 | 0.61–0.87 | 0.001* |
CBT0 | 0.54 | 0.39–0.69 | 0.589 |
CBT1000 | 0.59 | 0.45–0.74 | 0.212 |
APCB | 0.53 | 0.39–0.68 | 0.663 |
TCA | 0.59 | 0.44–0.73 | 0.237 |
Model 2. After cataract surgery Eyes with onset of malignant glaucoma vs. Matched eyes | |||
ACD | 1.00 | 0.99-1.00 | < 0.001* |
ACW | 0.57 | 0.43–0.72 | 0.322 |
LV | 1.00 | 1.00–1.00 | < 0.001* |
STS | 0.65 | 0.50–0.79 | 0.053 |
AVD | 1.00 | 1.00–1.00 | < 0.001* |
CBTmax | 0.86 | 0.76–0.96 | < 0.001* |
CBT0 | 0.76 | 0.64–0.89 | 0.001* |
CBT1000 | 0.73 | 0.60–0.85 | 0.003* |
APCB | 0.52 | 0.36–0.67 | 0.830 |
TCA | 0.83 | 0.73–0.93 | < 0.001* |